These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26935506)

  • 21. Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer.
    Cathcart MC; Gately K; Cummins R; Kay E; O'Byrne KJ; Pidgeon GP
    Mol Cancer; 2011 Mar; 10():25. PubMed ID: 21388528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overactivated neddylation pathway as a therapeutic target in lung cancer.
    Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L
    J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
    Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
    Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
    Li X; Wan L; Geng J; Wu CL; Bai X
    J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells.
    Selvakumar P; Lakshmikuttyamma A; Das U; Pati HN; Dimmock JR; Sharma RK
    Mol Cancer; 2009 Aug; 8():65. PubMed ID: 19703310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies.
    Varker KA; Phelps SH; King MM; Williams CL
    Int J Oncol; 2003 Mar; 22(3):671-81. PubMed ID: 12579323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo.
    Chen X; Xie S; Bhat S; Kumar N; Shapiro TA; Liu JO
    Chem Biol; 2009 Feb; 16(2):193-202. PubMed ID: 19246010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression.
    Clery E; Pisapia P; Feliciano S; Vigliar E; Marano A; De Luca C; Malapelle U; Troncone G; Bellevicine C
    J Clin Pathol; 2017 Sep; 70(9):798-802. PubMed ID: 28363898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic determinants of pemetrexed responsiveness and nonresponsiveness in non-small cell lung cancer cells.
    Wu MF; Hsiao YM; Huang CF; Huang YH; Yang WJ; Chan HW; Chang JT; Ko JL
    J Thorac Oncol; 2010 Aug; 5(8):1143-51. PubMed ID: 20559153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of P67/MetAP2 as a tumor suppressor.
    Datta B
    Biochim Biophys Acta; 2009 Dec; 1796(2):281-92. PubMed ID: 19716858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostacyclin synthase expression and epigenetic regulation in nonsmall cell lung cancer.
    Cathcart MC; Gray SG; Baird AM; Boyle E; Gately K; Kay E; Cummins R; Pidgeon GP; O'Byrne KJ
    Cancer; 2011 Nov; 117(22):5121-32. PubMed ID: 21523772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
    Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of V-ATPase is associated with drug resistance and pathology of non-small-cell lung cancer.
    Lu Q; Lu S; Huang L; Wang T; Wan Y; Zhou CX; Zhang C; Zhang Z; Li X
    Diagn Pathol; 2013 Aug; 8():145. PubMed ID: 23984887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non-small cell lung cancer cells.
    Lee BB; Kim Y; Kim D; Cho EY; Han J; Kim HK; Shim YM; Kim DH
    J Cell Mol Med; 2019 Apr; 23(4):2872-2889. PubMed ID: 30710424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells.
    Yu JA; Li H; Meng X; Fullerton DA; Nemenoff RA; Mitchell JD; Weyant MJ
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1479-85. PubMed ID: 23026567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of methionine aminopeptidase 2 in human colorectal adenocarcinomas.
    Selvakumar P; Lakshmikuttyamma A; Kanthan R; Kanthan SC; Dimmock JR; Sharma RK
    Clin Cancer Res; 2004 Apr; 10(8):2771-5. PubMed ID: 15102683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implications of microsomal prostaglandin e synthase-1 overexpression in human non-small-cell lung cancer.
    Wang HW; Hsueh CT; Lin CF; Chou TY; Hsu WH; Wang LS; Wu YC
    Ann Surg Oncol; 2006 Sep; 13(9):1224-34. PubMed ID: 16952028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer.
    Simi L; Venturini G; Malentacchi F; Gelmini S; Andreani M; Janni A; Pastorekova S; Supuran CT; Pazzagli M; Orlando C
    Lung Cancer; 2006 Apr; 52(1):59-66. PubMed ID: 16513206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
    Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
    Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.